Abstract
With the aim of finding selective and biologically active G-quadruplex ligands, modified porphyrin with bulky cationic substituents, meso-5,10,15,20-tetrakis(4-guanidinophenyl)porphyrin tetrahydrochloride, referred to as guanidinium phenyl porphyrin, was prepared. The corresponding nickel(II) and cobalt(III) metallated porphyrins were also synthesized. Interaction with quadruplexes was examined by means of fluorescence resonance energy transfer melting and surface plasmon resonance-based assays: the three compounds proved to bind to G-quadruplex DNA in a similar and highly selective way. Guanidinium phenyl porphyrin and its nickel(II) metallated derivative exhibit moderate cytotoxicity toward cells in culture. Strikingly, the nickel porphyrin derivative was able to displace hPOT1 shelterin protein from telomeres in human cells.
Graphical Abstract
Nickel(II) guanidinium phenyl porphyrin, a cationic bulky porphyrin is a powerful specific G-quadruplex DNA ligand. It enters the cells and induces shelterin modification.
Similar content being viewed by others
References
Balasubramanian S, Neidle S (2009) Curr Opin Chem Biol 13:345–353
Bidzinska J, Cimino-Reale G, Zaffaroni N, Folini M (2013) Molecules 18:12368–12395
Burge S, Parkinson GN, Hazel P, Todd AK, Neidle S (2006) Nucleic Acids Res 34:5402–5415
Neidle S (2010) FEBS J 277:1118–1125
Monchaud D, Granzhan A, Saettel N, Guédin A, Mergny JL, Teulade-Fichou MP (2010) J Nucleic Acids 2010. Article ID 525862
Granzhan A, Monchaud D, Saettel N, Guédin A, Mergny JL, Teulade-Fichou MP (2010) J Nucleic Acids 2010. Article ID 460561
Ou TM, Lu YJ, Tan JH, Huang ZS, Wong KY, Gu LQ (2008) Chem Med Chem 3:690–713
Maji B, Bhattacharya S (2014) Chem Commun 50:6422–6438
Oganesian L, Karlseder J (2009) J Cell Sci 122:4013–4025
Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR (1988) Proc Natl Acad Sci 85:6622–6626
Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW (1997) Genes Dev 11:2801–2809
de Lange T (2005) Genes Dev 19:2100–2110
Shay JW, Wright WE (1996) Curr Opin Oncol 8:66–71
Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW (1996) Dev Genet 18:173–179
Zahler AM, Williamson JR, Cech TR, Prescott DM (1991) Nature 350:718–720
Wheelhouse RT, Sun DK, Han HY, Han FXG, Hurley LH (1998) J Am Chem Soc 120:3261–3262
Izbicka E, Wheelhouse RT, Raymond E, Davidson KK, Lawrence RA, Sun D, Windle BE, Hurley LH, Von Hoff DD (1999) Cancer Res 59:639–644
Phan AT, Kuryavyi V, Gaw HY, Patel DJ (2005) Nat Chem Biol 1:167–173
Nicoludis JM, Barrett SP, Mergny JL, Yatsunyk LA (2012) Nucleic Acids Res 40:5432–5447
Bettelheim A, White BA, Raybuck SA, Murray RW (1987) Inorg Chem 26:1009–1017
Salehi A, Mei H-Y, Bruice TC (1991) Tetrahedron Lett 32:3453–3456
Renciuk D, Zhou J, Beaurepaire L, Guédin A, Bourdoncle A, Mergny JL (2012) Methods 57:122–128
Dijols S, Boucher JL, Lepoivre M, Lefevre-Groboillot D, Moreau M, Frapart Y, Rekka E, Meade AL, Stuehr DJ, Mansuy D (2002) Biochemistry 41:9286–9292
Witt JJ, Roskoski RJ (1980) Arch Bioch Biophys 201:36–43
De Cian A, Guittat L, Kaiser M, Saccà B, Amrane S, Bourdoncle A, Alberti P, Teulade-Fichou MP, Lacroix L, Mergny JL (2007) Methods 42:183–195
Murat P, Bonnet R, Van der Heyden A, Spinelli N, Labbe P, Monchaud D, Teulade-Fichou MP, Dumy P, Defrancq E (2010) Chem Eur J 16:6106–6114
Romera C, Bombarde O, Bonnet R, Gomez D, Dumy P, Calsou P, Gwan JF, Lin JH, Defrancq E, Pratviel G (2011) Biochimie 93:1310–1317
Riou JF, Guittat L, Mailliet P, Laoui A, Renou E, Petitgenet O, Megnin-Chanet F, Hélène C, Mergny JL (2002) Proc Natl Acad Sci 99:2672–2677
Pennarun G, Granotier C, Gauthier LR, Gomez D, Hoffschir F, Mandine E, Riou JF, Mergny JL, Mailliet P, Boussin FD (2005) Oncogene 24:2917–2928
Burger AM, Dai F, Schultes CM, Reszka AP, Moore MJ, Double JA, Neidle S (2005) Cancer Res 65:1489–1496
Gomez D, O’Donohue MF, Wenner T, Douarre C, Macadre J, Koebel P, Giraud-Panis MJ, Kaplan H, Kolkes A, Shin-ya K, Riou JF (2006) Cancer Res 66:6908–6912
Gomez D, Wenner T, Brassart B, Douarre C, O’Donohue MF, El Khoury V, Shin-ya K, Morjani H, Trentesaux C, Riou JF (2006) J Biol Chem 281:38721–38729
Gunaratnam M, Greciano O, Martins C, Reszka AP, Schultes CM, Morjani H, Riou JF, Neidle S (2007) Biochem Pharmacol 74:679–689
Salvati E, Leonetti C, Rizzo A, Scarsella M, Mottolese M, Galati R, Sperduti I, Stevens MF, D’Incalci M, Blasco M, Chiorino G, Bauwens S, Horard B, Gilson E, Stoppacciaro A, Zupi G, Biroccio A (2007) J Clin Invest 117:3236–3247
Loayza D, De Lange T (2003) Nature 423:1013–1018
Ramsay AJ, Quesada V, Foronda M, Conde L, Martinez-Trillos A, Villamor N, Rodriguez D, Kwarciak A, Garabaya C, Gallardo M, Lopez-Guerra M, Lopez-Guillermo A, Puente XS, Blasco MA, Campo E, Lopez-Otin C (2013) Nat Genet 45:526–530
Acknowledgments
We are grateful to Agence Nationale pour la Recherche (Quarpdiems grant ANR-12-BSV8-0008), Labex ARCANE (ANR-11-LABX-0003-01), Région Midi-Pyrénées, Région Aquitaine, Université Paul Sabatier, Toulouse for financial support. The authors acknowledge support from ICMG FR 2607 for providing synthesis and purification of oligonucleotides and SPR facilities.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sabater, L., Nicolau-Travers, ML., De Rache, A. et al. The nickel(II) complex of guanidinium phenyl porphyrin, a specific G-quadruplex ligand, targets telomeres and leads to POT1 mislocalization in culture cells. J Biol Inorg Chem 20, 729–738 (2015). https://doi.org/10.1007/s00775-015-1260-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-015-1260-8